[Federal Register Volume 86, Number 241 (Monday, December 20, 2021)]
[Notices]
[Pages 71902-71903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27482]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and contract proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Review of Radiation Oncology-Biology Integration Network 
(ROBIN) Centers.
    Date: February 3-4, 2022.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W640, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Rockville, Maryland 20850, 240-276-7684, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Drug Development Support TEP.
    Date: February 4, 2022.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5: NCI Clinical and Translational Cancer Research.
    Date: February 8-9, 2022.
    Time: 9:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248, Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Metabolic Dysregulation and Cancer Risk.
    Date: February 8, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-10: NCI Clinical and Translational Cancer Research.
    Date: February 22, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Biman Chandra Paria, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9606 Medical 
Center Drive, Room 7W552, Rockville, Maryland 20850, 202-731-8506, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational Cancer Research.
    Date: February 23-24, 2022.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Robert F. Gahl, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9606 Medical Center Drive, Room 
7W104, Rockville, Maryland 20850, 240-276-7869, [email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Institutional Training and Education Study Section (F).
    Date: February 23-24, 2022.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Research Specialist Award (R50).
    Date: February 24-25, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Rockville, Maryland 20850, 240-276-6372, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Translational and Basic Research Early Lesions (U54 and U24).
    Date: March 2-3, 2022.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Career Development Study Section (J).
    Date: March 3-4, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W624, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
    Date: March 17, 2022.
    Time: 10:00 a.m. to 6:00 p.m.

[[Page 71903]]

    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Informatics Technologies for Cancer Research.
    Date: March 30-31, 2022.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Rockville, Maryland 20850, 240-276-6371, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 15, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-27482 Filed 12-17-21; 8:45 am]
BILLING CODE 4140-01-P